Safety and Risk Factors of Propofol for Conscious Sedation During in Gastrocopy

WU Jian,HU Guo-yong,DING Yan-bing,LI Neng-nian,QIAN Su-hong

DOI: https://doi.org/10.3870/j.issn.1005-541X.2005.06.011

2005-01-01

Abstract:Objective This study characterizes propofol’s safety profile and evaluates risk factors in consecutive high-risk patients.Methods All 4 027 patients undergoing a gastrocopy procedure under sedation with propofol between January 2003 to December 2004 including outpatient and inpatient were eligible for inclusion in this retrospective study.Sedation was voluntary.Demographic data and clinical features were recorded.A structured personal history led to a 5-class risk stratification based on the criteria of the American Society of Anesthesiologists. 1 357 at risk-patients were sedated with propofol,of whom 33.7%(1036 ASA Ⅲ,321 ASAⅣ)were matched with 2 670 consecutive patients of the same gender and age assigned to ASA classes Ⅰ and Ⅱ.Anesthetist performed all sedations by propofol dose titration while carefully monitoring arterial oxygen saturation,heart rate,and blood pressure.Results No major complications occurred among the critically ill patients.There was,however,an increased risk for a short relevant oxygen desaturation (<90%) of 4.9% for ASA Ⅲ and Ⅳ versus 2.7% for ASA Ⅰ and Ⅱ (P<0.05).In all cases,increasing flow of inhaling oxygen and/or aspirating sputum was necessary.Also,a greater proportion of patients showed a>or=20% heart rate and a>or=25% mean arterial pressure decrease.Conclusion With careful monitoring,propofol sedation during gastrocopy is safe,even for high-risk patients.Considering their higher comorbidity and tendency toward oxygen desaturation,they need particularly careful monitoring.